TY - JOUR
T1 - Dyslipidaemia in rural Australia: prevalence, awareness, and adherence to treatment guidelines in the Greater Green Triangle Risk Factor Study
AU - Janus, Edward
AU - Tideman, Philip
AU - Dunbar, James
AU - Kilkkinen, Annamari
AU - Bunker, Stephen
AU - Philpot, Benjamin
AU - Tirimacco, Rosy
AU - McNamara, Kevin
AU - Heistaro, Sami
AU - Laatikainen, Tiina
PY - 2010/2/1
Y1 - 2010/2/1
N2 - Objectives: To determine population lipid profiles, awareness of hyperlipidaemia and adherence to Australian lipid management guidelines. Design and setting: Population survey in rural south-eastern Australia, 2004-2006. Participants: Stratified random sample from the electoral roll. Data from 1274 participants (40%) aged 25-74 years were analysed. Main outcome measures: Population mean total, low-density lipoprotein and high-density lipoprotein cholesterol (TC, LDL-C and HDL-C) and triglyceride (TG) concentrations, prevalence of dyslipidaemia, and treatment according to 2001 and 2005 Australian guideline target levels. Results: Population-adjusted mean TC, TG, LDL-C and HDL-C concentrations were 5.38mmol/L (95% CI, 5.30-5.45), 1.50mmol/L (95% CI, 1.43-1.56), 3.23mmol/L (95% CI, 3.16-3.30) and 1.46mmol/L (95% CI, 1.44-1.49), respectively. Prevalence of hypercholesterolaemia (TC > 5.5mmol/L or on treatment) was 48%. Lipid-lowering medication use was reported by 12%. Seventy-seven of 183 participants with established cardiovascular disease (CVD) or diabetes were untreated, and of the 106 treated, 59% reached the target LDL-C. Of those without CVD or diabetes already treated, 38% reached target LDL-C, and 397 participants at high absolute risk did not receive primary prevention. Ninety-five per cent of treated individuals with CVD or diabetes and 86% of others treated had cholesterol measured in the previous year. Sixty-nine per cent of individuals at low risk aged over 45 years had their cholesterol measured within the previous 5 years. Conclusions: A comprehensive national strategy for lowering mean population cholesterol is required, as is better implementation of absolute risk management guidelines - particularly in rural populations.
AB - Objectives: To determine population lipid profiles, awareness of hyperlipidaemia and adherence to Australian lipid management guidelines. Design and setting: Population survey in rural south-eastern Australia, 2004-2006. Participants: Stratified random sample from the electoral roll. Data from 1274 participants (40%) aged 25-74 years were analysed. Main outcome measures: Population mean total, low-density lipoprotein and high-density lipoprotein cholesterol (TC, LDL-C and HDL-C) and triglyceride (TG) concentrations, prevalence of dyslipidaemia, and treatment according to 2001 and 2005 Australian guideline target levels. Results: Population-adjusted mean TC, TG, LDL-C and HDL-C concentrations were 5.38mmol/L (95% CI, 5.30-5.45), 1.50mmol/L (95% CI, 1.43-1.56), 3.23mmol/L (95% CI, 3.16-3.30) and 1.46mmol/L (95% CI, 1.44-1.49), respectively. Prevalence of hypercholesterolaemia (TC > 5.5mmol/L or on treatment) was 48%. Lipid-lowering medication use was reported by 12%. Seventy-seven of 183 participants with established cardiovascular disease (CVD) or diabetes were untreated, and of the 106 treated, 59% reached the target LDL-C. Of those without CVD or diabetes already treated, 38% reached target LDL-C, and 397 participants at high absolute risk did not receive primary prevention. Ninety-five per cent of treated individuals with CVD or diabetes and 86% of others treated had cholesterol measured in the previous year. Sixty-nine per cent of individuals at low risk aged over 45 years had their cholesterol measured within the previous 5 years. Conclusions: A comprehensive national strategy for lowering mean population cholesterol is required, as is better implementation of absolute risk management guidelines - particularly in rural populations.
UR - http://www.mja.com.au/public/issues/192_03_010210/jan11290_fm.html
UR - http://www.scopus.com/inward/record.url?scp=77952350504&partnerID=8YFLogxK
U2 - 10.5694/j.1326-5377.2010.tb03449.x
DO - 10.5694/j.1326-5377.2010.tb03449.x
M3 - Article
VL - 192
SP - 127
EP - 132
JO - Medical Journal of Australia
JF - Medical Journal of Australia
SN - 0025-729X
IS - 3
ER -